sglt2 glp-1 news GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Cardiovascular benefits of SGLT2 inhibitors

What happens if I stop peptide therapy suddenly

This microenvironment was characterised by an 80% increase in adipocyte nuclei, larger adipocytes and activation of gene sets associated with adipogenesis including IGF-1 (Kang et al., 2020)

What is an advanced skincare routine for skin lightening

Obesity 31 , 537544 (2023)

No, around 40-60% of patients will experience a resolution of symptoms over time

Tissue perfusion and sexual function pathways A case report of female anorgasmia and hypoarousal temporally related to GLP-1 agonist use (including semaglutide after a switch from liraglutide) proposed mechanisms including smooth-muscle vasoconstriction with reduced genital blood flow and central neurotransmitter pathway effects (hypothalamic signalling)